Gilead's remdesivir gets conditional EU clearance
Video Credit: Reuters Studio - Duration: 00:59s - Published
Gilead's remdesivir gets conditional EU clearance
The European Commission said Friday it had given conditional approval for the use of antiviral drug remdesivir in severe COVID-19 patients.
As Fred Katayama reports, that makes it the region's first authorized therapy to treat the virus.
